Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck said on Tuesday a study showed that its injectable version of cancer drug Keytruda was not inferior to the currently ...

Merck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of ...